Who owns AEON BIOPHARMA I?
- CUSIP Number: 00791x118
Tip: Access positions for across all investors
Analyze quarterly positions in Aeon Biopharma I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Aeon Biopharma I stock
Who bought or sold AEON BIOPHARMA I this quarter?
There are no current stakeholders of Aeon Biopharma I.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Aeon Biopharma I?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Davidson Kempner Capital Management | Mar 2024 | 367k | $532k |
LMR Partners | Mar 2024 | 250k | $363k |
Wolverine Asset Management | Mar 2024 | 189k | $274k |
Tenor Capital Management | Mar 2024 | 167k | $242M |
Aristeia Capital | Mar 2024 | 164k | $251k |
D. E. Shaw & Co | Mar 2024 | 154k | $224k |
Millennium Management | Mar 2024 | 145k | $210k |
Q Global Advisors | Mar 2024 | 132k | $192k |
Hudson Bay Capital Management | Mar 2024 | 100k | $145k |
Whitebox Advisors | Mar 2024 | 92k | $133k |
Calamos Advisors | Mar 2024 | 83k | $121k |
Goldman Sachs Group | Mar 2024 | 80k | $115k |
Kim | Mar 2024 | 63k | $92k |
OZ Management | Mar 2024 | 50k | $76k |
DuPont Capital Management Corporation | Mar 2024 | 50k | $73k |
Farallon Capital Management | Mar 2024 | 50k | $73k |
Jane Street | Mar 2024 | 41k | $59k |
Moore Capital Management | Mar 2024 | 33k | $48k |
Polar Securities | Mar 2024 | 27k | $42k |
Sandia Investment Management | Mar 2024 | 20k | $29k |
Marshall Wace | Mar 2024 | 20k | $32k |
Hrt Financial | Mar 2024 | 19k | $27k |
Parallax Volatility Advisers | Mar 2024 | 12k | $18k |
Clear Street | Mar 2024 | 6.2k | $9.0k |